Description: Relvar Ellipta 100/25 Microgram is an inhalation powder used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). This combination medication contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, a long-acting beta2-agonist, which work together to reduce inflammation and relax airway muscles, making breathing easier.
Ingredients:
- Active Ingredients: Fluticasone Furoate 100 micrograms, Vilanterol 25 micrograms per inhalation
- Other Ingredients: Lactose monohydrate, Magnesium stearate
Usage Instructions:
-
Dosage: One inhalation once daily, at the same time each day.
-
Frequency: Once daily.
-
Special Considerations: Rinse mouth with water after inhalation to reduce the risk of oral thrush. Follow the instructions provided with the inhaler device for correct usage.
Benefits:
- Provides long-term control of asthma and COPD symptoms.
- Reduces the frequency and severity of asthma attacks and COPD exacerbations.
- Improves lung function and overall respiratory health.
Precautions:
-
Contraindications: Hypersensitivity to fluticasone furoate, vilanterol, or any other components of the product.
-
Side Effects: Common side effects include headache, nasopharyngitis, and cough. Serious side effects may include worsening breathing problems, allergic reactions, and adrenal suppression. Seek medical advice if you experience any severe side effects.
-
Warnings: Not for use in acute asthma attacks or sudden breathing problems. Use with caution in patients with cardiovascular disorders, thyroid disorders, or diabetes.
Storage Instructions:
- Store at room temperature (15-30°C).
- Keep away from direct sunlight and moisture.
- Keep the inhaler in the sealed tray until ready for use. Once opened, discard the inhaler after 6 weeks or when the counter reads "0," whichever comes first.
- Keep out of reach of children.
Manufacturer:
GlaxoSmithKline Pharmaceuticals
